Pyridam Farma Tbk PT
IDX:PYFA
Pyridam Farma Tbk PT
Short-Term Debt
Pyridam Farma Tbk PT
Short-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Short-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Short-Term Debt
Rp193B
|
CAGR 3-Years
15%
|
CAGR 5-Years
67%
|
CAGR 10-Years
21%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Short-Term Debt
Rp935.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
18%
|
CAGR 10-Years
22%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Short-Term Debt
Rp332.4B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
1%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Short-Term Debt
Rp0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Short-Term Debt
Rp0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Short-Term Debt
Rp2.2T
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
27%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Short-Term Debt?
Short-Term Debt
193B
IDR
Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Short-Term Debt amounts to 193B IDR.
What is Pyridam Farma Tbk PT's Short-Term Debt growth rate?
Short-Term Debt CAGR 10Y
21%
Over the last year, the Short-Term Debt growth was -89%. The average annual Short-Term Debt growth rates for Pyridam Farma Tbk PT have been 15% over the past three years , 67% over the past five years , and 21% over the past ten years .
